跳至主要内容
临床试验/ACTRN12620001374954
ACTRN12620001374954尚未招募未知

se of single lead ECG to assist cardioversion in atrial fibrillation in the Emergency department - a pilot study

Eastern Health0 个研究点目标入组 50 人开始时间: 2020年12月22日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 50 patients with AF onset less than 24 hours presenting to ED who are able to have delayed cardioversion.
  • Age: 18 years or greater
  • Residing within the Eastern Health catchment during the initial intervention period (48 hours from time of ED presentation)
  • Haemodynamically stable
  • Recent onset AF : <24 hours of symptomatic first episode or recurrent AF
  • Have compatible smart phone or tablet to use the Alivecor device

排除标准

  • AF onset time unclear.
  • History of long-standing persistent AF (continuous AF for more than 1 year)
  • Patients with haemodynamically unstable AF who require emergent cardioversion
  • Have a cardiac pacemaker or implantable cardioverter defribrillator or other implanted electronic device
  • Unable to provide informed consent

研究者

相似试验

The use of smart watch technology to improve the... | 临床试验